These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23803066)

  • 41. Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma.
    Najafi Z; Sharifi M; Javadi G
    Cancer Gene Ther; 2015 Nov; 22(11):530-5. PubMed ID: 26427512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
    Leung CM; Chen TW; Li SC; Ho MR; Hu LY; Liu WS; Wu TT; Hsu PC; Chang HT; Tsai KW
    Oncol Rep; 2014 May; 31(5):2147-56. PubMed ID: 24626680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of MicroRNAs by
    Mahmoudian-Sani MR; Asadi-Samani M
    Recent Pat Anticancer Drug Discov; 2020; 15(2):174-184. PubMed ID: 32603285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression.
    Yang N; Liang Y; Yang P; Yang T; Jiang L
    Braz J Med Biol Res; 2017 Jan; 50(1):e5794. PubMed ID: 28076456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing.
    Alotaibi MR; Hassan ZK; Al-Rejaie SS; Alshammari MA; Almutairi MM; Alhoshani AR; Alanazi WA; Hafez MM; Al-Shabanah OA
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):777-783. PubMed ID: 29582634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. microRNA-184 functions as tumor suppressor in renal cell carcinoma.
    Su Z; Chen D; Li Y; Zhang E; Yu Z; Chen T; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Exp Ther Med; 2015 Mar; 9(3):961-966. PubMed ID: 25667660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiRNA-429 suppresses the growth of gastric cancer cells in vitro.
    Liu D; Xia P; Diao D; Cheng Y; Zhang H; Yuan D; Huang C; Dang C
    J Biomed Res; 2012 Sep; 26(5):389-93. PubMed ID: 23554776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effects of sea buckthorn procyanidins on fatty acid synthase and MDA-MB-231 cells.
    Wang Y; Nie F; Ouyang J; Wang X; Ma X
    Tumour Biol; 2014 Oct; 35(10):9563-9. PubMed ID: 24957042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.
    Mori F; Ferraiuolo M; Santoro R; Sacconi A; Goeman F; Pallocca M; Pulito C; Korita E; Fanciulli M; Muti P; Blandino G; Strano S
    Oncotarget; 2016 Apr; 7(15):20532-48. PubMed ID: 26967561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suspension State Promotes Drug Resistance of Breast Tumor Cells by Inducing ABCC3 Overexpression.
    Wang Y; Zhang X; Zhao B; Xu Z; Lv Y
    Appl Biochem Biotechnol; 2020 Feb; 190(2):410-422. PubMed ID: 31367898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In silico and in vitro analysis of the impact of single substitutions within EXO-motifs on Hsa-MiR-1246 intercellular transfer in breast cancer cell.
    Rybarczyk A; Lehmann T; Iwańczyk-Skalska E; Juzwa W; Pławski A; Kopciuch K; Blazewicz J; Jagodziński PP
    J Appl Genet; 2023 Feb; 64(1):105-124. PubMed ID: 36394782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer: New delivery platform targets antimirs to tumours.
    Flemming A
    Nat Rev Drug Discov; 2014 Dec; 13(12):888. PubMed ID: 25435213
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
    Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
    Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.
    Yuan Y; Du W; Wang Y; Xu C; Wang J; Zhang Y; Wang H; Ju J; Zhao L; Wang Z; Lu Y; Cai B; Pan Z
    Int J Cancer; 2015 Mar; 136(6):1333-40. PubMed ID: 25066607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential of miR-153 as aggressive prostate cancer biomarker.
    Gilyazova I; Ivanova E; Sinelnikov M; Pavlov V; Khusnutdinova E; Gareev I; Beilerli A; Mikhaleva L; Liang Y
    Noncoding RNA Res; 2023 Mar; 8(1):53-59. PubMed ID: 36329790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells.
    Yousefnia S
    Front Oncol; 2022; 12():985897. PubMed ID: 36158686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous learning of individual microRNA-gene interactions and regulatory comodules.
    Roth M; Jain P; Koo J; Chaterji S
    BMC Bioinformatics; 2021 May; 22(1):237. PubMed ID: 33971820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-153 inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition in breast cancer via direct targeting of RUNX2.
    Zuo Z; Ye F; Liu Z; Huang J; Gong Y
    Exp Ther Med; 2019 Jun; 17(6):4693-4702. PubMed ID: 31086603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.